Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen Opens Boston Area Proteomics Center

NEW YORK, June 26 - Ciphergen has opened a new proteomics center in the Boston area, the company said late Wednesday.


The center will provide services based on the company's SELDI-based ProteinChip technology and its BioSepra protein purification system, including large-scale protein expression, development of chromatography purification, development of analytical methods for proteomics, and furtherance of biomanufacturing processes.


Lisa Bradbury, a senior scientist at Ciphergen, will manage the center.


Ciphergen also has a proteomics center in Cergy-Saint-Christophe, near Paris.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.